Emulsified Cannabinoid Formulation for Cognitive Decline
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments and management options do not effectively address memory-related disorders and cognitive decline associated with dementia and neurodegenerative diseases such as Alzheimer's and Parkinson's, nor do they enhance memory and cognitive function.
Innovation Solution
A scientifically-based brain health formulation combining emulsified CBD, THC, terpenes, antioxidants, spearmint extract, and film-forming agents to improve and maintain memory, cognition, and prevent symptoms of dementia and related disorders, with specific ratios and dosages of CBD, THC, terpenes, and antioxidants to enhance bioavailability and support brain health.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments and management options are used, then existing therapies are administered, but they do not effectively address memory-related disorders and cognitive decline
Solution Approach 1:
The patent combines multiple cannabinoids (CBD, THC, CBC, CBG) with terpenes and other nutraceuticals into a composite formulation designed to address memory-related disorders and cognitive decline, creating a synergistic treatment approach that overcomes the limitations of single-component therapies
2Adaptability or versatility
If CBD and THC are used for their known pharmacological effects, then anxiety, seizures, and pain are treated, but memory-related disorders are not addressed
Solution Approach 1:
The formulation is designed to perform multiple functions: it maintains the anxiolytic and anticonvulsant properties of CBD and THC while adding cognitive enhancement and memory improvement capabilities through specific cannabinoid ratios and complementary nutraceuticals, making the treatment versatile across multiple neurological conditions
3Object-affected harmful factors
If antioxidants are added to suppress free radical damage, then brain function decline is addressed, but bioavailability may be reduced
Solution Approach 1:
The patent uses emulsifiers and film-forming agents as intermediaries to enhance the bioavailability of antioxidant compounds and cannabinoids, ensuring these substances can effectively cross biological barriers and reach their target sites in the brain while maintaining their antioxidant properties
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation effectively improves cognitive function, prevents brain damage, slows the progression of Alzheimer's and dementia, and lessens symptoms, promoting new brain cell growth and enhancing memory and reaction performance without disrupting sleep.
Implementation Method 1
As an antioxidant, CBD works on oxidative stress and the prevention of reactive oxygen species (ROS), or free radicals
Implementation Method 2
THC also reduces inflammation which contributes to brain cell damage
Implementation Method 3
The formulation of the invention preferably further includes at least one film forming agent/solubilizer to enhance bioavailability of the formulation
Data Source
AI summary
The invention relates to a unique formulation for brain health. The formulation includes a mixture of CBD and THC and/or flavonoids, along with at least one antioxidant, and preferably an emulsifier, spearmint extract and a film-forming agent. The formulation improves memory and cognition as well as prevents and improves symptoms in dementia and related diseases related to deterioration or loss of memory and/or cognition.